Evidence map›Paper›PMID 37795187›Full record

ArticleFrontiers in neuroscience2023

The utility of peripheral stereopsis.

Preeti Verghese

Abstract read
In one paragraph

Article in Frontiers in neuroscience, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author.

Preeti VergheseSmith-Kettlewell Eye Research Institute, San Francisco, CA, United States.

Funding

Maximizing Visual Potential in Age-Related Macular DegenerationR01EY027390 · NEI · SMITH-KETTLEWELL EYE RESEARCH INSTITUTE · PI Preeti Verghese · 2017 to 2026
$5.7M
Stereopsis and Suppression in Strabismus and AmblyopiaR01EY034370 · NEI · SMITH-KETTLEWELL EYE RESEARCH INSTITUTE · PI VERGHESE, PREETI · 2022 to 2025
$1.6M
NEI NIH HHS R01 EY027390NEI NIH HHS R01 EY034370
6 · The paper itself

Abstract

This perspective article makes the case for evaluating and training peripheral stereopsis, particularly when the central visual field is compromised in one or both eyes. Examples of clinical conditions that preferentially affect the central visual field include macular degeneration, which affects the central macular region in one or both eyes, and amblyopia where the central field is often affected in one eye, but the peripheral field is largely intact. While binocular acuity may be preserved when the monocular central field of one eye is affected, fine stereopsis is compromised because it requires intact vision in corresponding locations in the two eyes. Even in these clinical conditions, recent studies that map stereoacuity at locations across the visual field demonstrate that the periphery supports coarse stereopsis, and that training efforts to use residual stereopsis may have greater benefit if they take this finding into account.

Indexed as

amblyopiacoarse stereopsismacular degenerationperipherystrabismus

Identifiers

PMID37795187
PMCPMC10545962

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.